Photo of Michel Sadelain from Memorial Sloan Kettering Cancer Center/LinkedIn
Sep 17, 2023, 16:13
Congratulations to Dr. Michel Sadelain for receiving the 2024 Breakthrough Prize Foundation’s Prize in Life Sciences for the development of chimeric antigen receptor T cell immunotherapy. – Memorial Sloan Kettering Cancer Center
Quoting Memorial Sloan Kettering Cancer Center on LinkedIn:
“Congratulations to Dr. Michel Sadelain, Director of the Center for Cell Engineering and the Gene Transfer and Gene Expression Laboratory at Memorial Sloan Kettering Cancer Center (MSK), for receiving the 2024 Breakthrough Prize Foundation‘s Prize in Life Sciences for the development of chimeric antigen receptor T cell immunotherapy.”
For details, click here.
Source: Memorial Sloan Kettering Cancer Center/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 12:13
Nov 13, 2024, 11:52
Nov 13, 2024, 11:48
Nov 13, 2024, 11:44
Nov 13, 2024, 11:39
Nov 13, 2024, 11:30
Nov 13, 2024, 11:25
Nov 13, 2024, 11:10
Nov 13, 2024, 10:59